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ABSTRACT 
Introduction: Prenatal depression (PND) is a common psychiatric disorder in pregnant 
women and leads to psychosocial dysfunction, high suicidal rate, and adverse childcare. 
Patients with PND have omega-3 polyunsaturated fatty acid (omega-3 or n-3 PUFAs) deficits, 
which might link to chronic low-grade inflammatory process and the pathophysiological 
mechanisms of depression. In this case-control study, we examined the levels of PUFAs and 
inflammatory cytokines in PND. 
Method: Blood samples were obtained and analyzed from 16 healthy controls and 17 
depressed cases (PND group) diagnosed with Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV). Independent sample t-test and correlation analysis were 
performed with Statistical Package for the Social Sciences (SPSS) logistics correlation 
analysis. 
Results: PND group had significantly lower levels of total n-3 (p=0.026), docosahexaenoic 
acid (DHA) (p=0.020) and eicosapentaenoic (EPA) (p=0.019) but a higher omega-6 (n-6)/n-3 
PUFAs ratio (p=0.007) and tumor necrosis factor alpha (TNF-α) (p=0.016) level. Moreover, 
the duration of current PND episodes were also significantly correlated with DHA, EPA, n-3 
PUFAs, n-6/n-3 ratio and TNF-α. In terms of PUFAs and cytokine levels, only DHA was 
inversely correlated with TNF-α. 
Conclusion: PND is significantly associated with lower DHA, EPA, and total n-3 PUFAs 
levels and an increased n-6/n-3 PUFAs ratio, while the duration of PND is associated with 
lower levels of n-3 PUFAs, including DHA and EPA. The correlation of PUFAs levels with 
depression and TNF-α level grant further investigation into the inflammatory process 
underlying PND, mediated by PUFAs. 
Keywords: Perinatal depression (PND), Polyunsaturated fatty acids (PUFAs), Major 
depressive disorder, Inflammation 
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1. INTRODUCTION 
Perinatal depression (PND) is major and minor depressive episodes that occur during 
pregnancy or within the first year after delivery (Gavin et al., 2005). PND is considered as 
one of the most common complications with prevalence rates ranging from 6.5%~ 12.9% 
(Bennett et al., 2004; Gavin et al., 2005; Serati et al., 2016; Su et al., 2007). PND is 
detrimental to the mothers since up to 20% postpartum deaths in women with PND are due to 
suicide (Lindahl et al., 2005). Moreover, PND further affects the mother-child interaction and 
further affect the child’s sense of insecurity in relationships (Marmorstein et al., 2004; Stein 
et al., 1991; Su et al., 2003). The unwanted consequences secondary to risky behaviors, 
including suicidal behaviors, unhealthy behaviors such as alcohol abuse (Bonari et al., 2004) 
and poor child care behaviors, have urged the need for exploring the pathophysiology and 
biochemical mechanisms underlying PND in anticipation of better and earlier interventions 
(Serati et al., 2016).  
Long-chain polyunsaturated fatty acids (LC-PUFA) serve an important role in cellular 
and physiological function in perinatal period, especially omega-3 PUFAs (n-3 PUFAs) such 
as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Chiu et al., 2004; 
Demmelmair and Koletzko, 2015; Su et al., 2008; Su et al., 2013). The association between 
PUFAs and PND has been explored in recent observational study (Shiraishi et al., 2015). For 
examples, prenatal depressive symptoms are associated with lower plasma DHA in Japanese 
population (Shiraishi et al., 2015). Another association study further indicates that patients 
with higher level of EPA and DHA have lowered risks for developing depressive symptoms 
(De Vriese et al., 2003), while a higher omega-6 (n-6)/n-3 ratio increases the odds of having 
depressive symptoms (De Vriese et al., 2003; Pinto et al., 2016). In contrast to the supporting 
evidence of PUFAs in PND, Sallis et al (Sallis et al., 2014) only found weak associations 
between n-3 PUFAs and PND. Chong et al also claimed that there was no significant 
association between n-3 PUFAs and PND, but rather an association between n-3 fatty acid 
and antenatal anxiety (Chong et al., 2015).  
The hypothesized mechanisms underlying PUFAs’ antidepressant effects are their action 
on neuroinflammation (Song et al., 2016; Su, 2009, 2012; Su, 2015). Indeed, several studies 
have supported the association between pro-inflammatory cytokines and depression (Dowlati 
et al., 2010; O'Brien et al., 2004; Schiepers et al., 2005; Su, 2012). The meta-analysis done 
by Dowlati et al., claimed that pro-inflammatory cytokines such as interleukin-6 (IL-6) and 
tumor necrosis factor alpha (TNF-α) increase in depressed subjects (Dowlati et al., 2010). 
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Raison et al. also revealed that levels of IL-6 and C-reactive protein (CRP) rise in peripheral 
circulation in depressive subjects (Raison et al., 2006), while IL-1β and TNF-α are increased 
in both blood and cerebrospinal fluid (CSF) (Raison et al., 2006). Moreover, antidepressants 
were shown to increase IL-10, which has an anti- inflammatory property (Raison et al., 2006). 
However, the associations of IL-6 and TNF-α in PND still remain inconclusive, since some 
studies found an increase of these pro- inflammatory cytokines in depression (Boufidou et al., 
2009; Christian, 2012; Christian et al., 2009; Maes et al., 2001), while similar findings were 
not obtained by other groups (Blackmore et al., 2011; Skalkidou et al., 2009). Hence, 
although both cytokines and n-3 PUFAs have been explored as potential biomarkers for PND, 
the findings have been controversial. In this observational study, we aimed to examine the 
role of n-3 PUFAs and inflammatory markers and cytokines, such as CRP, TNF-α, IL-6, and 
IL-10, in PND. We hypothesized that the subjects with PND will have higher levels of 
inflammatory markers including pro- inflammatory cytokine levels and n-6 PUFAs, and lower 
levels of anti-inflammatory markers including IL-10 and n-3 PUFAs. 
 
2. METHODS 
2.1 Subjects 
Thirty-three pregnant women (17 PND cases and 16 healthy controls) were enrolled in 
this study after informed consent had been obtained. The case-control study was conducted at 
the Department of Obstetrics of China Medical University Hospital (CMUH) in Taichung, 
Taiwan, where integrative care for pregnant woman was provided by the cooperation of a 
psychiatric team and obstetricians. The data was collected after ethical approval from the 
Institutional Review Board of the CMUH. 
The inclusion criteria of both PND and control group were pregnant women within in 
2nd trimester (16th week) or 3rd trimester (28th week) and have ages between 18 to 45 years. 
Among the 33 eligible participants, all are native Taiwanese and biologically unrelated. 
Moreover, none of the subjects were taking any psychotropic drugs or had any other medical 
illness upon comprehensive evaluation of medical history, physical examination and 
laboratory tests. The 17 PND cases were determined by certified psychiatrists, according to 
the diagnosis criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition (DSM-IV) (American Psychiatric Association, 1994) . Both 17 PND cases and 16 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
healthy controls also provided baseline blood samples for PUFAs and cytokine analysis 
between weeks 16 and 28 when they received the routine obstetric follow-up.  
2.2 Assessments 
2.2.1 Mini-International Neuropsychiatric Interview (MINI) 
MINI is a short structured clinical interview which enables researchers to make 
diagnoses of psychiatric disorders according to DSM-IV or ICD-10 (Sheehan et al., 1998). 
The administration time of the interview is approximately 15 minutes and the interview is 
designed for epidemiological studies and multicenter clinical trials.The information of 
translation, validation and instruction of Taiwanese version of MINI can be accessed on the 
website of Taiwanese Society of Psychiatry (http://www.sop.org.tw/dow_a.htm). 
2.2.2 Edinburgh Postnatal Depression Scale (EPDS) 
Pregnant women were assessed with Edinburgh Postnatal Depression Scale (EPDS) for 
perinatal depressive symptoms. EPDS has been the most well-known and widely used 
evaluation instrument for perinatal depression (Boyd et al., 2005; Chong et al., 2015). EPDS 
is a self-reported, 10-item screening questionnaire that has been tested in different cultures 
and countries. The sensitivity and specificity of EPDS varied among culture and different cut 
off points (Zubaran et al., 2010). The Taiwanese version of the Edinburgh Postnatal 
Depression Scale (EPDS-T) were validated and showed excellent sensitivity and specificity 
at the cut- off point of 12/13 (Su et al., 2007; Teng et al., 2005). The cut- off point of 12/13 
has also been recommended in the Spitzer’s Research Diagnostic Criteria (Spitzer et al., 
1978). Therefore, patient whose EPDS scored above 12/13 were identified as having perinatal 
depressive symptoms in this study.  
2.3 Laboratory assessment 
Blood samples were obtained in the morning (9:00-1000 am) after 12-hour fasting. 
Venous bloods were extracted into 10 ml K2 ethylenediaminetetraacetic acid tubes (BD, 
Franklin Lakes, NJ, USA) and were centrifuged at 1000g for 10 minutes (25°C) and 
plasma were stored at -80 C until further analysis. Patients enrolled in this study were 
assessed for the inflammatory markers including CRP, IL-6, IL-10 and TNF-α. Individual 
fatty acid profiles were also analyzed from the obtained blood samples. CRP levels were 
measured by nephelometry, a latex particle-enhanced immunoassay (TBA-200FR, Tokyo, 
Japan), using a fully automatic biochemical analyzer (Unicel DxC 800 Synchron Clinical 
System; Beckman Coulter, Fullerton, CA, USA) at the Clinical Laboratory Department of 
CMUH. The inter- and intra-assay coefficients of variations (CVs) were <2.0% and <1.9%, 
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respectively. The lower detection limit of the assay was 0.01 mg/dL. Plasma cytokine levels 
of IL-6, IL-10 and TNF-α were quantified by Bio-Plex Suspension Array System 200 
(Bio-Rad Laboratories, Hercules, CA, USA) along with a Procarta Immunoassay Kit using 
polystyrene beads and an appropriate diluent Plasma Standard Diluent Kit 
(Affymetrix-Panomics, Santa Clara, CA, USA). This analytic measure is based on the 
Luminex technology and a human cytokine/chemokine 6-plex panel was used to 
simultaneously detect the following analytes.  
Fatty acid composition of erythrocyte membranes was analyzed by thin-layer 
chromatography and the level of individual fatty acid was measured with gas chromatography 
of methyl esters (Lipid Standards, FAME, Sigma Co., St. Louis, MO, USA). Fatty acid 
profiles were identified by comparing the retention times with those of appropriate standard 
fatty acid methyl esters. The detailed step-by-step procedures have been published and 
described elsewhere (Chiu et al., 2003; Su, K. P. et al., 2003; Su et al., 2010). The levels of 
each fatty acid were expressed as a percentage of total fatty acids. Laboratory measures were 
conducted on coded samples by workers who were blind to the information of the subjects.  
2.4 Statistical analysis 
All statistical analysis was carried out with the Statistical Package for the Social Science 
(SPSS), version 17.0 for windows. Demographic and clinical characteristics of patients 
between PND and control groups were compared by t-test or Chi-Square test where 
appropriate. The correlation between PUFAs profile and cytokine levels was determined with 
Bivariate correlation using Pearson product-moment correlation coefficient as correlation 
coefficient (γ). The tests of significance for correlation analysis were two-tailed. Analyses 
were presented with 95% confidence intervals (CIs), and a p-value <0.05 was identified as 
statistically significant.  
 
3. RESULTS AND STATISTICAL ANALYSES 
3.1. Characteristics of participants 
There was no significant difference in terms of age, gestation times, education years, 
psychiatric or family history of MDD, and weeks of pregnancy (Table 1). As in coherence 
with the DSM-IV diagnosis, PND group had significantly higher EPDS score (p<0.0001) 
than control group. 
-------------------------------------------------- 
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 TABLE 1 
-------------------------------------------------- 
3.2. Polyunsaturated fatty acids and cytokine levels  
Patients with PND had significantly lower levers of total n-3 PUFAs (p= 0.026), EPA 
(p=0.019) and DHA (p=0.020) than control group (See Table 2). Moreover, PND group had a 
higher n-6/n-3 ratio than control group (p=0.007). Among the inflammatory biomarkers, only 
TNF-α was found to be significantly higher in PND group when compared to controls (p = 
0.016). Although no significant difference was found in AA or n-6 PUFAs, but there was a 
trend showing patients with PND had higher levels of AA and n-6 PUFAs than control group.  
-------------------------------------------------- 
 TABLE 2 
--------------------------------------------------  
 
3.3 Correlations of clinical variables and PUFA and cytokine levels 
 
There was no correlation between PND severity, PUFAs and cytokines levels. However, 
PND duration negatively correlated with total n-3 PUFAs, EPA and DHA, with r values equal 
to -0.415, -0.395 and -0.392 respectively (p<0.05, Table 3). Moreover, current PND duration 
positively correlated with n-6/n-3 ratio and TNF-α, with r values equal to 0.458 and .443, 
respectively (p<0.01, Table 3).  
-------------------------------------------------- 
 TABLE 3 
-------------------------------------------------- 
DHA was negatively correlated with TNF- α (p <0.05, Table 4), while no correlation 
was found between total n-3, n-6, n-3/n-6 ratio and EPA and cytokine levels.  
-------------------------------------------------- 
TABLE 4 
-------------------------------------------------- 
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4. DISCUSSION 
4.1 PND group had lower levels of n-3 PUFAs 
This is the first study measuring both PUFAs levels and inflammatory markers in 
women with PND. The major finding of our study is that pregnant women with PND had 
lower levels of EPA, DHA and total n-3 PUFAs and a higher n-6/n-3 PUFAs ratio. Our study 
findings support our initial hypothesis and corresponds to the meta-analysis showing lower 
n-3 PUFAs profiles of depressed patients in 14 case-control studies (Lin et al., 2010). 
Moreover, our study also showed pregnant women with PND tend to have higher levels of 
AA and n-6 PUFAs. This is further supported by other observational studies indicating that 
higher levels of EPA and DHA act as protective factor from MDD while a higher n-6/n-3 
ratio acts as a risk factor of MDD in pregnant women (De Vriese et al., 2003; Pinto et al., 
2016). Moreover, higher concentrations of DHA in breast milk and greater seafood 
consumption (rich in DHA) have been associated with lower prevalence rates of postpartum 
depression (Hibbeln, 2002). It has also been suggested that n-3 PUFAs are crucial for fetal 
development, and the increased demand during pregnancy may increase risk of PND in the 
susceptible mothers (De Vriese et al., 2003; Golding et al., 2009; Levant et al., 2008; 
Markhus et al., 2013; Su et al., 2003). In addition, DHA and EPA have shown efficacy in 
treating and preventing depressive disorders (Baghai et al., 2011; Clayton et al., 2009; Lin et 
al., 2010; McNamara et al., 2010).  
4.2 PND group had higher levels of TNF-α  
In terms of the inflammatory cytokines, our initial hypothesis was only partially proven, 
where TNF-α was observed to increase significantly in PND in this study. Physiological 
pregnancy has been suggested as a state of immunosuppression, to avoid maternal attack on 
the fetus (Kraus et al., 2012), while inflammation in pregnancy has been more commonly 
associated with pregnancy complications such as pre-eclampsia (Ahn et al., 2011), preterm 
birth (Osborne and Monk, 2013) and gestational diabetes (Lowe et al., 2010). The increased 
TNF-α levels observed in PND is supported by previous research reports (Boufidou et al., 
2009; Christian, 2012; Christian et al., 2009; Maes et al., 2001), thus inflammation involving 
TNF-α is speculated as a potential mechanism contributing to PND. The role of inflammation 
has been emphasized in depression, and an excellent example of inflammation theory of 
depression is interferon-α induced depression, where administration of inflammatory 
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cytokines results in depression (Su et al., 2014). On the other hand, blockade of 
pro-inflammatory cytokines and their signaling pathways and factors has been shown to 
reduce depressive symptoms in patients with MDD (Abbott et al., 2015; Kohler et al., 2014; 
Song et al., 2015; Song et al., 2016; Su, 2015; Su et al., 2015). Hence, inflammatory 
cytokines, particularly TNF-α may serve as a biological indicator or even as a harbinger of 
PND. 
4.3 Duration of PND associates with lower levels of n-3 PUFAs 
 The duration of PND associated positively with lower levels of total n-3 PUFAs, EPA 
and DHA and a higher n-6/n-3 PUFAs ratio. This further implies that the progression of PND 
might alter the erythrocyte profiles of PUFAs and enhance inflammatory response. Pregnancy 
is a state consisting of both physiological and psychological stress that may trigger the release 
of pro-inflammatory cytokines which later lead to neurotransmitter alterations and behavioral 
changes (Maier and Watkins, 1998). Although glucocorticoids may help to halt the 
pro-inflammatory cytokine production in acute phase, the development of glucocorticoid 
resistance as the result of chronic stress, such as depression, may result in excess production 
and accumulation of pro-inflammatory cytokines in the system (Maes et al., 1998; Pariante et 
al., 1999).  
N-3 PUFAs such as DHA, on the other hand, has been shown to have anti-inflammatory 
effects via immunomodulation and counteracting HPA axis dysfunction. For example, Song 
et al (Song and Wang, 2011) suggested that DHA could reduce the production of certain 
pro-inflammatory cytokine that leads to depression. Other studies further demonstrated that 
n-3 PUFAs induce suppression of eicosanoids by inhibiting TNF-α, IL-6 and IL-1β (James et 
al., 2000; Park et al., 2012). It has also been suggested that n-3 PUFAs are able to inhibit the 
actions of leukotriene B-4 (LTB-4), which is synthesized from n-6 derived arachidonic acid 
(AA). In addition, anti-inflammatory effect of DHA in depression has also been suggested to 
involve the monoamine neurotransmitter system and the HPA axis, where DHA is able to 
attenuate the hyperactivity of the HPA axis (Cowen, 2008; McNamara et al., 2010). Hence, 
n-3 PUFAs such as DHA and EPA may be serving as potential protective factors of PND in 
pregnant women. 
4.4 Limitations 
Due to the nature of observational study, we were not able to determine the casual 
relationship among DHA, EPA, cytokine levels and depression. Though our sample size is 
small, the case and control groups in this study are relatively homogenous in terms of age, 
education level, psychiatric and family history of MDD, smoking habits and gestation weeks, 
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which generally serve as confounding factors. By minimizing the heterogeneity of 
confounding factors, we enhance the validity of the results. There are other limitations, such 
as the lack of dietary controls and records of n-3 PUFAs consumption and the wide range of 
recruitment time points from weeks 16 to 28. Replication of our study with a longitudinal 
model study will be needed to support our findings. The strength of this study is that it is the 
first study measuring both PUFAs levels and inflammatory markers in women with PND. 
Moreover, the associations of n-3 PUFAs and cytokine levels in our study correspond well 
with other studies. 
 
5. CONCLUSION 
PND is significantly associated with lower DHA, EPA, and total n-3 PUFAs, and 
increased n-6: n-3 PUFAs ratio, while longer duration of depressive episode is associated 
with lower n-3 PUFAs. DHA is inversely associated with pro-inflammatory cytokine such as 
TNF-α in PND. Future studies with larger sample size are also required to replicate our 
findings and to help elucidate the inflammation mechanism with regards to PUFAs in patients 
with PND.  
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Table 1 Demographic data of the perinatal depression (PND) group and control group 
 
DEP  
(N=17)  
CONTROL 
(N=16) 
p 
Demographic characteristics 
Age (years), mean (SD) 31.2 (4.3) 30.6 (5.5) 0.699 
Education years, , mean (SD)  16.6(1.5) 16.8(1.0) 0.725 
Cigarette smoking, N (%) 0 (0) 0 (0) ---- 
Gestation Week, mean (SD) 23.2 (4.9) 23.2(2.8) 0.994 
Clinical characteristics 
Family history of psychiatric disorders, N 
(%) 
1 (3)  0(0) 
0.325 
EPDS, mean (SD) 14.6(3.6) 5.3(3.8) <0.0001 
PND Weeks, mean (SD) 7.7(2.4) 0(0) ---- 
History of Psychiatric Disorders, N (%) 3(9) 2 (6) 0.680 
Note: CONTROL, non-depression group; DEP, depression group; EPDS, Edinburgh Postnatal 
Depression Scale; N, number; PND Weeks, duration of current perinatal depression in weeks; 
SD, standard deviation. 
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Table 2 Polyunsaturated fatty acid profiles and cytokine levels  
 
DEP  
(N=17)  
CONTROL  
(N=16) 
p 
EPA (%) 2.6 (0.7) 3.1 (0.4) 0.019 
DHA (%) 3.7 (0.7) 4.2 (0.5) 0.020 
AA (%) 8.9 (1.3) 8.2 (0.6) 0.070 
Total N-3 (%) 8.6 (1.1) 9.4 (0.8) 0.026 
Total N-6 (%) 16.0 (1.9) 15.0 (1.4) 0.090 
N-6/N-3 1.91 (0.38) 1.61 (0.16) 0.007 
IL-10 (pg/ml) 1.5 (1.5) 2.0 (1.3) 0.389 
IL-6 (pg/ml) 7.8 (3.2) 6.5 (1.8) 0.146 
TNF-alpha (pg/ml) 1.1 (0.48) 0.7 (0.4) 0.016 
CRP (mg/L) 0.8 (0.2) 0.8 (0.1) 0.182 
Note: AA, arachidonic acid; CONTROL, non-depression group; CRP, high-sensitivity C-reactive 
protein; DEP, depression group; DHA, docosahexaenoic Acid; EPA, eicosapentaenoic acid; IL, 
interleukin; N, number; N-3, omega-3; N-6, omega-6; SD, standard deviation; TNF, tumor 
necrosis factor.  
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Table 3 Correlations of depression duration, severity, PUFAs, and cytokines 
 EPA 
R 
DHA 
R 
N-3 
R 
N-6/N-3 
R 
CRP 
R 
IL-6 
R 
IL-10 
R 
TNF-α 
R 
PND 
Weeks 
-.395* -.392* -.415* .458** .304 .264 -.105 .443** 
EPDS -.121 -.233 -.157 .280 .142 .123 -.248 .273 
Note: DHA, docosahexaenoic Acid; EPA, eicosapentaenoic acid; EPDS, Edinburgh Postnatal 
Depression Scale; N-3, omega-3; N-6, omega-6; N-6/N-3, omega-6: omega-3 ratio; PND 
Weeks, duration of current perinatal depression in weeks; R, Pearson coefficient; TNF, tumor 
necrosis factor. 
* indicates statistical significance of p<0.05; ** indicates statistical significance of p<0.01 
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Table 4 Correlation of polyunsaturated fatty acids and inflammatory cytokine levels  
 TNF alpha 
R 
IL-10 
R 
IL-6 
R 
CRP 
R 
EPA -.137 -.081 -.130 -.038 
DHA -.397* .055 -.209 -.257 
N-3 -.169 .003 .021 -.003 
N-6 .083 .148 -.034 -.103 
N-6/N-3 .243 .036 .003 -.018 
Note: CRP, C- reactive protein; DHA, docosahexaenoic Acid; EPA, eicosapentaenoic acid; IL, 
interleukin; N-3, omega-3; N-6, omega-6; N-6/N-3, omega-6 to omega-3 ratio; R, Pearson 
coefficient; TNF, tumor necrosis factor.  
* indicates statistical significance of p<0.05 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
HIGHLIGHTS 
 Blood samples of Prenatal depression (PND) cases were analysed for immune 
biomarkers  
 Blood samples of PND cases were analysed for n-3 fatty acids (PUFAs). 
 PND is significantly associated with lower DHA, EPA and total n-3 PUFAs 
 PND is significantly associated with increased n-6/n-3 PUFAs ratio and TNF-α level. 
 Duration of PND is associated with lower n-3 PUFAs levels and higher TNF-α level. 
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